TW200507851A - A parmaceutical compositions to be absorbed via lung - Google Patents

A parmaceutical compositions to be absorbed via lung

Info

Publication number
TW200507851A
TW200507851A TW093120837A TW93120837A TW200507851A TW 200507851 A TW200507851 A TW 200507851A TW 093120837 A TW093120837 A TW 093120837A TW 93120837 A TW93120837 A TW 93120837A TW 200507851 A TW200507851 A TW 200507851A
Authority
TW
Taiwan
Prior art keywords
absorbed via
via lung
phenyl group
substituted phenyl
parmaceutical
Prior art date
Application number
TW093120837A
Other languages
English (en)
Inventor
Kiyoshi Morimoto
Yumiko Satoh
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of TW200507851A publication Critical patent/TW200507851A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
TW093120837A 2003-07-14 2004-07-13 A parmaceutical compositions to be absorbed via lung TW200507851A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003273805 2003-07-14

Publications (1)

Publication Number Publication Date
TW200507851A true TW200507851A (en) 2005-03-01

Family

ID=34056038

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093120837A TW200507851A (en) 2003-07-14 2004-07-13 A parmaceutical compositions to be absorbed via lung

Country Status (2)

Country Link
TW (1) TW200507851A (zh)
WO (1) WO2005004875A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266181A (zh) * 2011-09-08 2011-12-07 鲁杨 一种具有保健功能的枕头

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3088672B2 (ja) * 1995-12-01 2000-09-18 三共株式会社 飽和複素環化合物
JPH1143490A (ja) * 1997-05-30 1999-02-16 Sankyo Co Ltd 光学活性スルホキシド誘導体の塩
PL340736A1 (en) * 1997-12-03 2001-02-26 Fujisawa Pharmaceutical Co Drug in the form of soft granules and method of obtaining same
JP2000034288A (ja) * 1998-01-23 2000-02-02 Sankyo Co Ltd スピロピペリジン誘導体
IL149935A0 (en) * 1999-12-02 2002-11-10 Osi Pharm Inc Compounds specific to adenosine a1, a2a and a3 receptors and uses thereof
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
WO2005004875A1 (ja) 2005-01-20

Similar Documents

Publication Publication Date Title
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
CA2534625A1 (en) Infection prophylaxis using immune response modifier compounds
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
BR0312729A (pt) Novos derivados de indol-3-enxofre
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
BR0311494A (pt) Novos indóis substituìdos
TW200728307A (en) Novel spirochromanone derivatives
BR0108893B1 (pt) composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos.
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
DK1767535T3 (da) Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
NO20065061L (no) Benzoksazin for behandling av sykdommer i luftveiene
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
AR049681A1 (es) Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas
EA200602016A1 (ru) ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ
SI1831239T1 (sl) Postopek za pripravo gamma laktona hidroksi beta beta beta beta bismetilen alfa pregn en on karboksilne kisline in ključniintermediati za ta postopek
HK1076816A1 (zh)
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
MXPA05005790A (es) Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central.
GEP20084470B (en) New phenylpyridinylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
EA200400214A1 (ru) Азитромицин в виде разовой дозы
SE0303480D0 (sv) Benzofuranes
AR057555A1 (es) Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo
NO20081587L (no) Aerosolformulering for inhalering